Ozone-induced bronchial epithelial cytokine expression differs between healthy and asthmatic subjects

Clin Exp Allergy. 2003 Jun;33(6):777-82. doi: 10.1046/j.1365-2222.2003.01662.x.

Abstract

Background: Ozone (O3) is a common air pollutant associated with adverse health effects. Asthmatics have been suggested to be a particularly sensitive group.

Objective: This study evaluated whether bronchial epithelial cytokine expression would differ between healthy and allergic asthmatics after ozone exposure, representing an explanatory model for differences in susceptibility.

Methods: Healthy and mild allergic asthmatic subjects (using only inhaled beta2-agonists prn) were exposed for 2 h in blinded and randomized sequence to 0.2 ppm of O3 and filtered air. Bronchoscopy with bronchial mucosal biopsies was performed 6 h after exposure. Biopsies were embedded in GMA and stained with mAbs for epithelial expression of IL-4, IL-5, IL-6, IL-8, IL-10, TNF-alpha, GRO-alpha, granulocyte-macrophage colony-stimulating factor (GM-CSF), fractalkine and ENA-78.

Results: When comparing the two groups at baseline, the asthmatic subjects showed a significantly higher expression of IL-4 and IL-5. After O3 exposure the epithelial expression of IL-5, GM-CSF, ENA-78 and IL-8 increased significantly in asthmatics, as compared to healthy subjects.

Conclusion: The present study confirms a difference in epithelial cytokine expression between mild atopic asthmatics and healthy controls, as well as a differential epithelial cytokine response to O3. This O3-induced upregulation of T helper type 2 (Th2)-related cytokines and neutrophil chemoattractants shown in the asthmatic group may contribute to a subsequent worsening of the airway inflammation, and help to explain their differential sensitivity to O3 pollution episodes.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Air Pollutants / adverse effects*
  • Asthma / immunology*
  • Bronchi / immunology*
  • Case-Control Studies
  • Chemokine CXCL5
  • Chemokines, CXC*
  • Cytokines / analysis*
  • Disease Susceptibility
  • Epithelium / immunology
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / analysis
  • Humans
  • Immunohistochemistry / methods
  • Interleukin-4 / analysis
  • Interleukin-5 / analysis
  • Interleukin-8 / analogs & derivatives*
  • Interleukin-8 / analysis
  • Male
  • Ozone / adverse effects*

Substances

  • Air Pollutants
  • CXCL5 protein, human
  • Chemokine CXCL5
  • Chemokines, CXC
  • Cytokines
  • Interleukin-5
  • Interleukin-8
  • Interleukin-4
  • Ozone
  • Granulocyte-Macrophage Colony-Stimulating Factor